|Articles|June 17, 2023
News Roundup: June 12 to June 16
Your weekly roundup of the latest news from Drug Topics®.
Advertisement
How the Workplace Can Impact Respiratory Health
A recent study examined the effects that different work environments can have on adults with asthma.
Biosimilar Infliximab Not Shown to Cause Adverse Outcomes in Patients With IBD
Hesitation from patients and providers to switch to an infliximab biosimilar may not be necessary, new study finds.
Tapinarof Cream 1% Shows Positive Topline Results for Treatment of Pediatric Atopic Dermatitis
According to Dermavant, tapinarof cream 1% is a novel, aryl hydrocarbon receptor agonist in development as a once-daily topical cream.
CGM Use May Lead to Behavioral Modifications in Adolescent T2D
Generative AI Framework Could Help Create Better Medicine Faster
G2Retro, developed by investigators from Ohio State University, can produce hundreds of new reaction predictions in just a few minutes.
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Related Content
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Why It’s Crucial to Address Insulin Resistance During Pregnancy
2
Investigators Link Maternal Distress With Neurodevelopmental Delay Among Children
3
Investigators Evaluate Decline in Percentage of Patients With COPD Using Inhaled Corticosteroids
4
Q&A: The Initiative Bringing Clinical Pharmacy Care to Underserved Patients’ Homes
5
